Results 111 to 120 of about 50,960 (274)
The effects of DAA-I on the profile of leucocytes and platelet in gamma irradiated mice.
, 2015 Control-1: animals were administered 0.1 ml vehicle (water) and were not irradiated. Control-2: animals were administered vehicle and were irradiated. Control-3: animals were administered 800 nmole/kg DAA-I and were not irradiated.
Meng-Kwoon Sim (796860) +3 more
core +1 more source
Parenting Program for Families in Contexts of Social Vulnerability Within the Spanish Red Cross
Family Relations, EarlyView.ABSTRACT Objective The main aim of the present study was to test the impact of the Parenting Team Program (PTP), an intervention for families in contexts of social vulnerability with children aged 0–6 years, carried out in the regional offices of the Spanish Red Cross.
Florencia Barreto‐Zarza +3 more
wiley +1 more source
Retreatment of Direct Acting Agents (DAAs) After Initial DAA Failure in Hepatitis C Patients
Hepatology ResearchABSTRACT Background and Aims Glecaprevir/pibrentasvir (GLE/PIB) and sofosbuvir/ledipasvir (SOF/LDV) are widely used as first‐line direct‐acting antiviral (DAA) regimens for chronic hepatitis C, achieving high virus eradication rates.
Nobuharu Tamaki +10 more
openaire +2 more sources
ACES M and S: Unmitigated Factorial Encounter Study on DAA/TCAS Interoperability [PDF]
, 2016 Realization of the expected proliferation of Unmanned Aircraft System (UAS) operations in the National Airspace System (NAS) depends on the development and validation of standards for UAS Detect and Avoid (DAA) Systems.
Park, Chunki +4 more
core
Overall and genotype-dependent efficacy of DAA treatment (mITT analysis).
, 2019 Overall and genotype-dependent efficacy of DAA treatment (mITT analysis).
Silvia García-Bujalance (7329716) +30 more
core +1 more source
Hepatology Research, EarlyView.ABSTRACT Background and Aims Patients with chronic hepatitis C and advanced fibrosis remain at substantial risk of hepatocellular carcinoma (HCC) and non‐liver–related death even after sustained virological response (SVR) to direct‐acting antivirals (DAA).
Daisuke Sakon +19 more
wiley +1 more source
Hepatology Research, EarlyView.Although the number of HCV antibody‐positive patients in ophthalmology departments has decreased, the proportion requiring referral for DAA therapy has not declined despite the widespread use of DAAs. Furthermore, combining HCV antibody titer determination with EMR review improves the efficiency of identifying patients requiring referral.
Ritsuzo Kozuka +21 more
wiley +1 more source
Proyecto implementación del sistema DAA - PMP
, 2009 El documento presenta una detallada descripción de las actividades ejecutadas en la administración del proyecto conducente a la evaluación e implementación del sistema informático DAA-PMP.
Martínez Cuba, Cesar Augusto
core
DAA‐PASS: A Prospective Evaluation of HCC Recurrence After Direct Acting Antiviral Therapy
: Direct-acting antiviral (DAA) therapy is associated with a significant reduction in hepatocellular carcinoma (HCC) incidence among patients with cirrhosis, but data are conflicting about the risk of recurrence following DAA therapy.
null, null +14 more
core +1 more source
HIV Medicine, EarlyView.Abstract Objectives Among people with HIV with hepatitis C virus (HCV) co‐infection, we examined differences in haemoglobin A1c (HbA1c), total cholesterol (TC), low‐density lipoprotein (LDL), high‐density lipoprotein (HDL) and atherosclerotic cardiovascular disease (ASCVD) risk score at 12‐months following direct acting antiviral (DAA) initiation ...
Raynell Lang +16 more
wiley +1 more source